Transplant Service Documentation Requirements
Customize your policy alerts
Sign up for Community Health Plan Washington Policy MC.CP.MP.247 alerts
Get alerted when Policy MC.CP.MP.247 changes without checking for updates manually.
Monitor payer policy activity
Documentation and prior-authorization requirements for pre‑transplant evaluation, transplant listing, and post‑transplant follow-up for solid organ and stem cell transplants; applies to providers requesting transplant-related services from the health plan.
No material clinical or coverage changes in this revision.
Medical Necessity & Coverage Criteria
Documentation-based medical necessity criteria
Requests are medically necessary when ALL of the following documentation elements are provided according to request type:
Applies to stem cell and solid organ transplant evaluations
Includes organ-specific items
Separate authorizations apply for transplant admissions
This policy's documentation requirements apply to solid organ and hematopoietic stem cell transplant requests and do not apply to certain other transplant types. Specifically, documentation requirements in this policy do not apply to corneal transplant, pancreatic islet cell auto‑transplant after pancreatectomy, or parathyroid auto‑transplant after thyroidectomy. For those procedures, providers must complete the Health Plan–specific prior authorization form as noted on the Health Plan website.
Coding & Test Recency
| CPT ® (referenced) | CPT codes referenced in policy for informational purposes; specific codes not enumerated in the document. |
Prior Authorization & Provider Requirements
Prior Authorization Required
Prior authorization is required for transplant evaluations, transplant listings, and post‑transplant follow‑up office visits. Approved evaluation authorizations are effective for six months; approved transplant listing authorizations are effective for 12 months. Inpatient transplant admissions require a separate authorization.
- Evaluation authorizations effective period: 6 months
- Listing authorizations effective period: 12 months
- Inpatient transplant admissions require separate authorization
Multiple facilities / Additional evaluations
Authorizations for services at multiple facilities or for additional evaluations after a transplant listing or prior evaluation approval are allowed when medically necessary. Examples include a change in transplant eligibility due to an intervening illness, or admission to a geographically closer facility when the member is not stable for transfer to the previously approved facility.
- Medically necessary when: member has an episode of illness changing eligibility
- Medically necessary when: member admitted to closer facility and not stable for transfer
Required documentation
Providers must submit the appropriate prior authorization form plus the required clinical documentation specific to the type of request (evaluation, initial/subsequent listing, post‑transplant follow‑up, or continuity of care). See the detailed documentation list below.
- Evaluation requests: prior authorization form; complete history & physical within 1 year (history of present illness with current meds, past medical/family/social history, review of systems, physical exam including height, weight, BMI)
- Listing requests (initial/subsequent): prior authorization form; signed letter of medical necessity from transplant service provider; complete H&P by transplant service provider within 12 months (history of present illness with current meds; past/family/social history; review of systems; physical exam incl. height, weight, BMI); complete chemistry panel/liver function tests and CBC within 12 months; appropriate testing/imaging/documentation specific to organ (e.g., liver: INR, MELD/PELD, biopsy as indicated; kidney: GFR or creatinine clearance if not on dialysis; heart: echo, right heart cath including PVR, NYHA class, peak VO2; lung: PFTs, chest imaging, six‑minute walk test); annual dental evaluation/clearance; routine preventive screening per standards of care; appropriate comorbidity testing/clearance (including cardiology); serum or urine drug screen within 90 days; infectious disease screening as specified; detailed psychosocial evaluation within 12 months
Missing or expired documentation — impact
Requests missing required documentation or with expired documentation will be impacted per policy. Examples include missing prior authorization form, missing or outdated H&P, expired labs or infection screening, absent drug screen, or missing dental/psychosocial clearances. Continuity of care requests must include documentation of previous insurer coverage, prior authorization by the previous insurer, and a copy of the UNOS listing.
- Missing or expired items may require resubmission or new authorization: prior authorization form, H&P, labs, infection screening, drug screen, dental or psychosocial evaluation
- Continuity of care requirements: documentation of previous insurer coverage; documentation of prior authorization by previous insurer; copy of UNOS listing
Background & Rationale
The purpose of the pre‑transplant evaluation is to identify conditions that can affect a candidate's ability to achieve a successful transplant and tolerate surgery and postoperative recovery. The evaluation assesses overall health, disease stage, infectious risk, comorbidities, and biologic compatibility to determine transplant candidacy. The policy bases its documentation expectations on established guidance (KDIGO, ISHLT, UNOS) and requires many clinical assessments to be current (generally within 12 months) to ensure decisions reflect accurate, up‑to‑date clinical data.
Key Definitions
Organ-specific Candidate Testing & Criteria
Organ-specific candidate testing
Organ-specific testing and documentation required for listing requests:
References UNOS MELD/PELD guidance
References KDIGO guidance
References ISHLT/UNOS guidance
References ISHLT consensus
Contraindications & Exclusions
This policy emphasizes identifying conditions that would complicate surgery or adversely affect postoperative recovery and outcomes. While the document does not enumerate an exhaustive list of absolute or relative contraindications, it directs reviewers and clinicians to derive specific contraindications from the cited clinical guidelines (KDIGO, ISHLT, UNOS). In practice, contraindications are those medical or psychosocial conditions that materially increase perioperative risk or undermine the benefits of transplantation and should be documented and considered during the evaluation.
Pre-Transplant Evaluation Requirements
Complete evaluation requires H&P, labs, organ‑specific testing, infectious disease screening, dental and psychosocial clearance
A comprehensive pre‑transplant evaluation must include a complete history and physical, appropriate laboratory testing, organ‑specific testing/imaging, infectious disease screening, dental clearance, routine preventive screenings, comorbidity testing/clearance, serum or urine drug screen, and a detailed psychosocial evaluation; many items must be current (generally within 12 months, drug screen within 90 days).
- Complete history and physical (H&P) within one year including HPI, medication list, past medical, family and social history, ROS, and physical exam with height/weight/BMI
- Complete chemistry panel/liver function tests and CBC within 12 months
- Organ‑specific testing (e.g., INR/MELD for liver; GFR/creatinine clearance for kidney; echocardiogram/right heart cath/peak VO2 for heart; PFTs and six‑minute walk for lung)
- Annual dental evaluation/clearance
- Infectious disease screening per policy (CMV, VZV, EBV, toxoplasma for heart, PPD/T‑Spot/QuantiFERON, hepatitis B and C, RPR, HIV with follow‑up testing if positive)
- Serum or urine drug screen within 90 days
- Detailed psychosocial evaluation within 12 months
Transplant Center & Facility Requirements
Use participating facilities and follow prior authorization processes; inpatient admissions need separate authorization
Transplants must occur at a participating facility and authorizations for transplant evaluations, listings, and post‑transplant follow‑up are processed per the health plan's prior authorization requirements; inpatient transplant admissions require a separate authorization from evaluation or listing authorizations.
Post-Transplant Follow-up Coverage
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.